NCT02981862 (CaptHPV) is a NA clinical trial of CaptHPV method in Cervical Cancer, sponsored by Institut de Cancérologie de Lorraine.

Who is sponsoring NCT02981862?

NCT02981862 is sponsored by Institut de Cancérologie de Lorraine.

What drugs are being tested in NCT02981862?

Interventions in NCT02981862: CaptHPV method.

Is NCT02981862 still recruiting?

NCT02981862 is currently completed. Last updated 31 August 2021.

Last reviewed 2021-08-31 · How we verify

NCT02981862: CaptHPV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas

Completed NA Last updated 31 August 2021

What this trial tests

NA trial testing CaptHPV method in Cervical Cancer in 100 participants. Completed in 12 June 2018.

Timeline

19 December 2016

Primary endpoint
12 June 2018

12 June 2018

Quick facts

Lead sponsor	Institut de Cancérologie de Lorraine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	100
Start date	19 December 2016
Primary completion	12 June 2018
Estimated completion	12 June 2018
Sites	1 location across France

Drugs / interventions tested

CaptHPV method

Conditions studied

Cervical Cancer — all drugs for Cervical Cancer →
Vulvar Cancer — all drugs for Vulvar Cancer →
Anal Cancer — all drugs for Anal Cancer →
Oropharynx Cancer — all drugs for Oropharynx Cancer →

Sponsor

Institut de Cancérologie de Lorraine — full company profile →

Who can join

18 and older, any sex, with Cervical Cancer or Vulvar Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current project is based on the assumption that a diagnosis of human papillomavirus associated Infiltrating Carcinomas can be made from a blood sample for patient with Cervical Cancer, Vulvar Cancer, Anal Cancer, Oropharynx Cancer, Oral Cavity Cancer or Penis Cancer at any stage of the disease and including surgical treatment for the small tumors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization.
Sastre-Garau X, Diop M, Martin F, Dolivet G, et al · · 2021 · cited 35× · PMID 34108183 · DOI 10.1158/1078-0432.ccr-21-0293

Verify or expand the search:

Other recruiting trials for Cervical Cancer

Currently open trials in the same condition.

NCT07276360 — Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · Phase 2 · recruiting
NCT05570422 — A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 · Phase 1 · recruiting
NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting
NCT07256236 — SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer · Phase 2 · recruiting

Other Institut de Cancérologie de Lorraine trials

Trials by the same sponsor.

NCT07326800 — Efficacy of the MAEva Program (Meditation, Acceptance, and Commitment to Values) Among Patients Treated For Breast Cance · NA · recruiting
NCT07089485 — Impact of Anesthesia Alarm Volume on Mental Workload in Surgical Trainees · NA · not yet recruiting
NCT07165756 — "Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot S · recruiting
NCT06884332 — Spinal Palliation in Irradiation for Neoplastic Analgesia and Life Quality · NA · recruiting
NCT06903104 — Acceptability and Feasibility of a Stress Prevention Program Based on Meditation and Acceptance and Commitment Therapy f · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02981862 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut de Cancérologie de Lorraine
Last refreshed: 31 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02981862.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing